台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.7
  • 漲跌
    ▼0.3
  • 漲幅
    -0.44%
  • 成交量
    82
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-元大-林森 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-林森 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/2800.00169.3069.50-1244-0.41%
2024/03/26171.0000.0069.3012410.41%
2024/03/2200.00162.3064.30-1230-0.43%
2024/03/0700.00567.1064.50-5209-2.39%
2024/03/0400.000.159.7060.20-0.1193-0.04%
2024/03/012.954.3400.0054.802.91831.59%
2024/02/23152.9000.0052.2011820.55%
2024/02/22351.0000.0051.1031821.64%
2024/02/21346.9700.0047.0031821.64%
2024/02/20148.2000.0048.3011800.55%
2024/02/19151.5000.0052.5011840.54%
2024/02/16251.9000.0052.0021831.09%
2024/02/0500.000.149.0050.50-0.1164-0.03%
2024/02/01243.2500.0043.8521531.31%
2024/01/31145.100.144.1545.600.91490.59%
2024/01/30241.3000.0041.5021401.42%
2024/01/26139.1500.0040.0011400.71%
2024/01/25239.5800.0039.6021421.40%
2024/01/23239.9800.0039.9521481.35%
2024/01/22439.5900.0039.6041542.58%
2024/01/15140.7000.0041.1511870.53%
2024/01/11441.0100.0039.6042001.99%
2024/01/09239.4000.0039.2522350.85%
2023/11/2000.000.441.0041.10-0.4181-0.19%
2023/10/2600.00131.0031.00-196-1.03%
2023/03/06016.1000.0016.050150.03%
2022/07/1400.00112.2512.40-1103-0.96%
2022/05/31113.5000.0013.7011460.68%
2022/03/1400.00214.3014.25-277-2.59%
2021/11/2900.00216.8017.00-2101-1.98%
2021/11/18215.1000.0015.202822.44%
2021/11/1100.00216.0516.00-282-2.44%
2021/07/02115.4500.0015.4014710.21%
2021/07/01115.4500.0015.4514710.21%
2021/06/21116.0500.0015.7014760.21%
2021/06/160.616.4000.0016.450.64770.13%
2021/06/110.216.9000.0016.900.24770.03%
2021/05/1800.00118.0017.90-1535-0.19%
2021/05/17118.70119.0019.6005060.00%
2021/05/1400.00118.0017.90-1459-0.22%
2021/05/1300.00419.0119.55-4434-0.92%
2021/05/11216.1300.0016.2023520.57%
2021/04/13218.98218.1018.2003220.00%
2021/04/08217.3000.0017.2522730.73%
2021/02/2300.00518.5717.45-5193-2.59%
2021/02/19115.1000.0016.0011710.58%
2021/02/01215.1000.0015.2521971.01%
2021/01/29115.0500.0015.0011980.50%
2020/12/01118.6000.0018.7013730.27%
2020/11/1300.00120.0019.55-1413-0.24%
2020/11/1200.00119.6019.30-1416-0.24%
2020/11/11220.2800.0020.3024250.47%
2020/11/1000.00120.0020.20-1420-0.24%
2020/11/06118.5000.0018.6514300.23%
2020/10/22221.75322.2021.20-1561-0.18%
2020/10/20219.6500.0019.8025460.37%
2020/10/1400.001015.2615.40-10671-1.49%
2020/10/0700.00216.7316.85-2946-0.21%
2020/10/06217.5000.0017.1021,0750.19%
2020/09/17118.5000.0018.6011,3620.07%
2020/09/0400.00119.8019.40-11,809-0.06%
2020/08/21220.3000.0021.1522,0470.10%
2020/08/18122.1000.0022.2012,1780.05%
2020/08/05125.1500.0025.0512,2890.04%
2020/07/29525.06425.0625.5512,2730.04%
2020/07/24627.7300.0027.0062,2360.27%
2020/07/2300.00730.1828.80-72,233-0.31%
2020/07/2100.00127.0027.45-12,149-0.05%
2020/07/2000.00124.2025.00-12,109-0.05%
2020/07/17426.7500.0026.1542,0680.19%
2020/07/16229.5300.0029.0522,0180.10%
2020/07/15228.58129.1030.8011,9830.05%
2020/07/14132.20332.0029.60-21,907-0.10%
2020/07/13431.23231.0831.5521,7930.11%
2020/07/10123.60428.7028.70-31,666-0.18%
2020/07/01223.6000.0024.0021,4200.14%
2020/06/18122.8500.0022.8511,3720.07%
2020/06/17126.20125.5525.3501,3500.00%
2020/06/16225.45325.4825.90-11,294-0.08%
2020/06/1500.00123.1524.20-11,207-0.08%
2020/06/12221.3000.0022.0021,1240.18%
2020/06/11220.981320.2421.00-111,077-1.02%
2020/06/10318.2700.0019.1039850.30%
2020/06/02216.7500.0016.6029660.21%
2020/05/29418.50117.9018.5039730.31%
2020/05/28518.52517.9218.5009780.00%
2020/05/27322.322222.8719.45-19947-2.00%
2020/05/222617.42216.9017.90249302.58%
2020/05/19213.5000.0013.5028120.25%
2020/05/0700.00312.6512.55-3767-0.39%
2020/05/05212.45112.5012.4017420.13%
2020/04/28111.6000.0011.6017030.14%
2020/04/1300.0019.689.56-1683-0.15%
2020/04/09110.0019.309.9006920.00%
2020/04/0118.5500.009.1016830.15%
2020/03/1200.00210.4510.35-2584-0.34%
2020/03/06114.3500.0014.7515020.20%
2020/03/0500.00615.5714.35-6482-1.24%
2020/03/04515.000.615.0514.954.44590.95%
2020/03/03214.8500.0015.4524340.46%
2020/02/2600.006513.4014.05-65321-20.19%
2020/02/256512.80112.2012.806426424.16%
2020/02/24111.501211.5511.65-11218-5.03%
2020/02/19210.0000.0010.2021711.16%
2020/02/17210.0000.0010.0021701.18%
2020/02/03211.0300.0010.3021461.36%
2020/01/31211.3000.0011.0521361.46%
2020/01/30411.7400.0011.7541283.12%
2019/12/0600.0019.709.65-192-1.08%
2019/10/1600.00610.1510.10-6137-4.37%
2019/10/09610.4800.0010.4061404.28%
2019/10/0400.00110.8510.85-1146-0.68%
2019/10/03110.5500.0010.5011480.67%
2019/09/240.311.0000.0010.900.31820.16%
2019/08/2800.0039.859.85-3148-2.02%
2019/07/22111.7500.0011.7511400.71%
2019/07/02210.8000.0010.852772.58%
2019/05/230.39.9100.009.800.31030.34%
2019/04/0200.00112.5012.50-1151-0.66%
2019/03/29112.4500.0012.3011510.66%
2019/02/1100.00212.5012.60-2115-1.73%
2019/01/14214.0000.0014.002942.12%
2019/01/0800.00111.3012.20-161-1.62%
2019/01/04111.0500.0011.001541.84%
2018/04/16221.3800.0021.3523290.61%
2018/03/22219.3500.0019.1021871.06%
2018/02/12116.8000.0017.0011950.51%
2018/02/06217.8000.0017.4021951.02%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音